Enrichment of TPPP/p25 in inclusion bodies of synucleinopathies and its interaction with α-synuclein and β-amyloid, promoting their aggregation in-vitro, implicates this protein in the etiology of several neurological diseases [11, 12]. The gene discussed is TPPP; the disease is synucleinopathy.